• BioSpace: Harnessing Nature for Faster mRNA Vaccine Manufacturing

    6 monthes ago - By Green Light Biosciences

    GreenLight CEO, Andrey Zarur, speaks to Biospace about the potential of a messenger RNA vaccine for Covid-19
    Andrey Zarur, Ph.D., president and CEO of GreenLight Biosciences.
    With manufacturing capacity in the news following the announcement of successful Covid-19 vaccine trials, Greenlight Biosciences CEO Andrey Zarur explains to Biospace the potential of the messenger RNA vaccine:
    “The silver lining in the pandemic is that it occurred at a time when companies like BioNTech, Pfizer and Moderna had been developing messenger RNA. It's the only reason we can respond as quickly as we are...
    Read more ...

     

  • CNBC: The challenges of Covid-19 vaccine production for the masses

    CNBC: The challenges of Covid-19 vaccine production for the masses

    6 monthes ago - By Green Light Biosciences

    CNBC speaks to GreenLight CEO, Andrey Zarur, about the challenge of vaccine production for Covid-19.
    Credit: Dado Ruvic | Reuters
    Andrey Zarur is founder and CEO of GreenLight Biosciences, and spoke to CNBC about vaccine production and how the fact that it requires more than one dose might prove a significant hurdle.
    “The MMR jab combines three vaccines in a single dose, precisely because it is much harder to get a patient to visit the healthcare center three times than once...In the USA, multi-dose vaccines for HPV and hepatitis have sometimes had only 40% of people get fully vaccinated...
    Read more ...

     

  • Metro: how Covid vaccine could transform the world

    Metro: how Covid vaccine could transform the world

    6 monthes ago - By Green Light Biosciences

    GreenLight CEO, Andrey Zarur, talks to Metro about supply issues with the Covid vaccine and how to make RNA.
    Credit: Metro.co.uk
    GreenLight CEO Andrey Zarur tells Metro about supply chain problems for the Covid vaccine and how to make RNA to help break the bottleneck:
    “There are a few suppliers of nucleotides worldwide... they are operating at capacity. Essentially, if everybody goes out and buys nucleotides, we will for sure have a supply issue
    “RNA constitutes as much as 5% of all the biomass of the planet...so it would be crazy not to try to make RNA the way nature has decided.
    ‘We need...
    Read more ...

     

  • Daily Mail: Suppliers of vaccine materials do not have capacity

    Daily Mail: Suppliers of vaccine materials do not have capacity

    6 monthes ago - By Green Light Biosciences

    GreenLight CEO, Andrey Zarur, has been quoted in the Daily Mail about supply chain issues relating to vaccine materials for Covid-19.
    Credit: Anadolu Agency via Getty Images
    Andrey Zarur, chief executive of GreenLight Biosciences, has been quoted in the Daily Mail about the capacity issues of suppliers of vaccine materials. He said:
    ‘The supply chain is just not mature enough. They have existed for laboratory-scale processes, which need nanograms, but they have to go from nanogram scale, to kilogram scale,' he added.
    Read the full articles here , here and here .
    Find out more about how...
    Read more ...

     

  • Unherd: Will a vaccine stop Covid?

    Unherd: Will a vaccine stop Covid?

    6 monthes ago - By Green Light Biosciences

    GreenLight CEO, Andrey Zarur, speaks to Unherd about vaccine production for Covid-19.
    Credit: Juan Carlos Lucas/NurPhoto/Getty Images
    GreenLight CEO, Andrey Zarur, speaks to Unherd about the supply chain issues related to vaccine production and manufacturing for Covid-19. He said:
    “Making an adenovirus particle has never been scaled...there just aren't enough reactors in the world [to create two billion doses by the end of the year]”. “When Moderna says they're going to make a billion doses by the end of 2021...it's about calling on suppliers and saying how much nucleotide can you...
    Read more ...

     

  • Fortune: If we don't vaccinate the world quickly, all our COVID efforts will be a waste

    Fortune: If we don't vaccinate the world quickly, all our COVID efforts will be a waste

    6 monthes ago - By Green Light Biosciences

    GreenLight CEO, Andrey Zarur, writes for Fortune about vaccine rollout for Covid-19.
    Credit: ALEX EDELMAN-GETTY IMAGES
    GreenLight CEO, Andrey Zarur, wrote an opinion piece for Fortune about the need for the Covid-19 vaccine rollout to happen quickly to contain the virus. He said:
    “To beat back this pandemic...we need herd immunity. ..We must inoculate at least 75% of the world's 7.7 billion people... Achieving this requires a sharp shift from our current ad hoc approach... With the current plans, there is no way that three-quarters of the world will ever be vaccinated-which means none of...
    Read more ...

     

  • Investors Business Daily: Vaccine manufacturing challenge

    Investors Business Daily: Vaccine manufacturing challenge

    6 monthes ago - By Green Light Biosciences

    GreenLight CEO, Andrey Zarur, speaks to for Investor's Business daily about the challenge of vaccine manufacturing for Covid-19.
    Credit: Elizabeth Plumb/shutterstock.com
    GreenLight CEO, Andrey Zarur, spoke to Investor's Business Daily about the Covid-19 vaccine manufacturing challenge, with billions around the world in need. He said:
    “The question that you ask becomes really, really relevant when we are trying to vaccinate a couple billion people... There's no way to do that in a day. There's just not enough infrastructure to go out and vaccinate 100 million people a day. That's not going...
    Read more ...